Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldman Sachs Alternatives is the alternative investment platform within Goldman Sachs Asset Management, managing over $450 billion in assets across private equity, credit, real estate, and infrastructure. The firm maintains a dedicated Life Sciences investment strategy that focuses on growth-oriented private equity and venture capital investments throughout the healthcare ecosystem. Their primary areas of interest include innovative biotechnology, pharmaceutical services, medical technology, and healthcare information technology. By leveraging the global network and deep industry expertise of the broader Goldman Sachs organization, the group provides strategic capital to help scale transformative healthcare businesses. Notable investment vehicles include the West Street Life Sciences I fund, which represents one of the largest first-time private life sciences growth funds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goldman Sachs Alternatives.